Expired CME Article

Osteonecrosis of the Jaw

The first bisphosphonate (etidronate) was approved by the FDA in 1977; alendronate was approved in 1995 for the prevention and treatment of osteoporosis. Bisphosphonates have emerged as the agents of choice for the treatment of osteoporosis and have proved useful in the treatment of skeletal complications of malignancy (hypercalcemia, bone…

Posted in: bisphosphonate 4 osteonecrosis 4 Osteoporosis 29